КИПРОЛИС
amgen europe b.v., Нидерланды - Карфилзомиба - Карфилзомиба
БЛИНЦИТО
amgen europe b.v., Нидерланды - blinatumomab - blinatumomab
ЭНПЛЕЙТ
amgen europe b.v., Нидерланды - romiplostim - romiplostim
ЭНПЛЕЙТ
amgen europe b.v., Нидерланды - romiplostim - romiplostim
ВЕКТИБИКС
amgen europe b.v., Нидерланды - Панитумумаб - Панитумумаб
НЕУЛАСТИМ
amgen europe b.v., Нидерланды - Пегфилграстим - Пегфилграстим
ПРОЛИА
amgen europe b.v., Нидерланды - Деносумаб - Деносумаб
ВЕКТИБИКС
amgen europe b.v., Нидерланды - Панитумумаб - Панитумумаб
Мимпара 30 mg
amgen europe b.v. - cinacalcet hydrochloride 30 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.
Мимпара 60 mg
amgen europe b.v. - cinacalcet hydrochloride 60 mg - film coated tablets - cinacalcet - treatment of secondary hyperparathyrodism (hpt) in patients with end-dtage renal disease (esrd) on maintenance dialysis therapy. mimpara may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with parathyroid carcinoma.